← Back to Clinical Trials
Recruiting NCT06521918

NCT06521918 Combined Artificial Intelligence and Mobile Application for Remote Infant Motor Screening: Development and Validation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06521918
Status Recruiting
Phase
Sponsor National Taiwan University Hospital
Condition Motor Disorders
Study Type OBSERVATIONAL
Enrollment 242 participants
Start Date 2024-10-17
Primary Completion 2027-07-31

Eligibility & Interventions

Sex All sexes
Min Age 2 Months
Max Age 18 Months
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 242 participants in total. It began in 2024-10-17 with a primary completion date of 2027-07-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study is therefore five-fold: (1) designation of an APP "Baby Go" version 3.0 to include the assessment, follow-up, and education functions for parental use at home, (2) development and validation of the AI algorithm for infant motor assessment based on home videos obtained from term and preterm infants, (3) comparison of parental perception and report with AI-driven assessment results, (4) examination of the predictive validity of the AI algorithm for infant motor assessment on subsequent outcome, and (5) investigation of the usability of the APP "Baby Go" version 3.0 in parents and clinicians.

Eligibility Criteria

The inclusion criterion is: Preterm infants: gestational age \< 37 weeks, birth body weight \< 2,500 grams, and corrected age of 2-18 months. Term infants: gestational age 37-42 weeks, birth body weight \>2,500 grams, and age of 2-18 months. Clinicians: who provide early intervention to the participating infants in this study. The exclusion criterion is: Infants: parents can not read Chinese. Clinicians: can not read Chinese

Contact & Investigator

Central Contact

Suh-Fang Jeng, Professor

✉ jeng@ntu.edu.tw

📞 886-2-33668132

Principal Investigator

Suh-Fang Jeng, Professor

PRINCIPAL INVESTIGATOR

School and Graduate Institute of Physical Therapy, National Taiwan University

Frequently Asked Questions

Who can join the NCT06521918 clinical trial?

This trial is open to participants of all sexes, aged 2 Months or older, up to 18 Months, studying Motor Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06521918 currently recruiting?

Yes, NCT06521918 is actively recruiting participants. Contact the research team at jeng@ntu.edu.tw for enrollment information.

Where is the NCT06521918 trial being conducted?

This trial is being conducted at Taipei, Taiwan, 100, Taiwan.

Who is sponsoring the NCT06521918 clinical trial?

NCT06521918 is sponsored by National Taiwan University Hospital. The principal investigator is Suh-Fang Jeng, Professor at School and Graduate Institute of Physical Therapy, National Taiwan University. The trial plans to enroll 242 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology